Published on 7 Feb 2024 on GuruFocus.com via Yahoo Finance
Phibro Animal Health Corp (PAHC) Reports Mixed Q2 Results and Revises FY2024 Guidance
Net Sales: Increased by 2% to $249.9 million in Q2.Net Income: Decreased by $5.9 million to $1.3 million in Q2.Adjusted EBITDA: Decreased by 5% to $29.5 million in Q2.Adjusted Net Income: Slightly decreased by 2% to $13.5 million in Q2.Adjusted Diluted EPS: Decreased by 2% to $0.33 in Q2.Guidance: FY2024 net sales guidance affirmed; Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS guidance updated.
Warning! GuruFocus has detected 8 Warning Signs with PAHC.
On February 7, 2024, Phibro Animal Health Corp (NASDAQ:PAHC) released its 8-K filing, detailing the financial outcomes for the second quarter ended December 31, 2023. The company, a diversified animal health and mineral nutrition entity, reported a modest increase in net sales but faced a significant decrease in net income and a slight dip in adjusted EBITDA.